Zobrazeno 1 - 10
of 265
pro vyhledávání: '"B. Paule"'
Autor:
Y. Sutter, Federica Caffaro, Federica Giuliani, Natalia Sokół, Aicha Diakite, R. Viula, B. Paule, V. R. M. Lo Verso
This paper presents selected results from the first stage of DAYKE (Daylight Knowledge in Europe), a 3-phase project that investigates the knowledge on daylighting in buildings among architecture students and practitioners across Europe. Subjective j
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d008ea32f8b54962c3101cdd06891034
https://hdl.handle.net/11590/372126
https://hdl.handle.net/11590/372126
Autor:
B. Paule
Publikováno v:
Oncologie. 7:387-390
La constatation que le recepteur EGF (Epidermal Growth Factor Receptor) et PDGFR (Platelet- Derived Growth Factor Receptor) sont impliques dans les metastases osseuses ouvre de nouvelles perspectives therapeutiques. Il s’agit d’une nouvelle appro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ec6efc2c73a45d9e4799fd7dab26d25c
https://doi.org/10.1007/s10269-005-0245-6
https://doi.org/10.1007/s10269-005-0245-6
Autor:
B. Paule
Publikováno v:
ONCOLOGIE. 6:445-449
Les bisphosphonates (BP) inhibent la resorption osseuse associee aux metastases osseuses osteoblastiques et interferent avec leur formation et leur croissance. Plusieurs etudes randomisees et non randomisees indiquent que les BP peuvent etre utilises
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::753105fa6728e22f2bef558553f188a8
https://doi.org/10.1007/s10269-004-0109-5
https://doi.org/10.1007/s10269-004-0109-5
Publikováno v:
International Journal of Pharmaceutics. 134:99-104
Eight patients with advanced renal cell cancer were treated in a phase II trial with interferon alpha 2a (9–18 MIU/m 2 subcutaneously) three days a week and all-trans retinoic acid (ATRA) 100 mg/m 2 /day orally in three equal fractions 7 h apart. A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e65dec7d7afb85c450ae58aad69fae4a
https://doi.org/10.1016/0378-5173(95)04452-3
https://doi.org/10.1016/0378-5173(95)04452-3
Publikováno v:
Lighting Research and Technology. 28:11-17
Zenithal openings are attractive because they provide a high illuminance level. Nevertheless, this type of opening may create glare or overheating due to the penetration of direct sunlight. Convent...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd844c94f8fde66449ad1a65c8ac7a98
https://doi.org/10.1177/14771535960280010201
https://doi.org/10.1177/14771535960280010201
Publikováno v:
Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie. 20(7)
We report a case of renal medullary carcinoma concerning a 38-year-old woman. Heterozygote sickle cell trait was noticed in her past medical history. The physical examination was unremarkable. The CT-scan revealed a left renal mass of 48 mm x 20 mm,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d64ff036be66ea62be4d3f9e3227350e
https://pubmed.ncbi.nlm.nih.gov/20656278
https://pubmed.ncbi.nlm.nih.gov/20656278
Autor:
B. Paule
Publikováno v:
African Journal of Urology; Vol 14, No 1 (2008): ; 29-36
Deux récents essais randomisés Phase III (TAX 327 et SWOG 9916) ont montré que le docetaxel améliorait la survie des cancers de la prostate hormonorésistants. Des drogues comme la mitoxantrone, la vinorelbine, le saraplatin et l\'épothylone son
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::944cc7778a8efcb96e5b872f54c74432
https://www.ajol.info/index.php/aju/article/view/8225
https://www.ajol.info/index.php/aju/article/view/8225
Publikováno v:
Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie. 18(13)
Surgery for osseous metastases seems to improve the patients with renal cell carcinoma. The goal of this study is to evaluate the efficacy and safety of surgery for osseous metastases from renal cell carcinoma.We performed 21 surgery for osseous meta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::36cf6f316f9bc8c65a6d429882f4a48e
https://pubmed.ncbi.nlm.nih.gov/19041809
https://pubmed.ncbi.nlm.nih.gov/19041809
Autor:
Lepillé D, Zannetti A, Florence Joly, E. Ecstein-Fraisse, Pierre Kerbrat, Gomez P, Genet D, Alain Ravaud, Hérait P, J.-C. Eymard, B. Paule, Frank Priou
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 18(6)
Background: Docetaxel (Taxotere®)-based regimens are the new standard therapy in advanced hormone-refractory prostate cancer (HRPC). A synergistic activity has been shown with docetaxel in combination with estramustine in vitro; however, the benefit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a27f5c107db3f8a39f80d5fc3539cf1d
https://pubmed.ncbi.nlm.nih.gov/17434899
https://pubmed.ncbi.nlm.nih.gov/17434899